Ethyl pyruvate improves survival in awake hemorrhage

Journal of Molecular Medicine

Volumn 87, Issue 4, 2009, Pages 423-433

  Cai, Bolin ^a   Brunner, Michael ^a   Wang, Haichao ^b   Wang, Ping ^b   Deitch, Edwin A ^a   Ulloa, Luis ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Cytokines; Ethyl pyruvate; Hemorrhage; Inflammation; Resuscitation; TNF

Indexed keywords

HETASTARCH; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HEART; INFLAMMATION; LIVER; LUNG; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTECTION; RAT; RESUSCITATION; SPLEEN; SURVIVAL RATE;

ANESTHESIA; ANIMALS; CONSCIOUSNESS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIVER; LUNG; MALE; MYOCARDIUM; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC; SPLEEN; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WAKEFULNESS;

EID: 64149090699     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0441-8     Document Type: Article

References (55)

1. PM Mannucci M Levi 2007 Prevention and treatment of major blood loss N Engl J Med 356 2301 2311
2. GD Rushing LD Britt 2008 Reperfusion injury after hemorrhage: a collective review Ann Surg 247 929 937
3. L Ulloa KJ Tracey 2005 The "cytokine profile": a code for sepsis Trends Mol Med 11 56 63
4. L Ulloa 2005 The vagus nerve and the nicotinic anti-inflammatory pathway Nat Rev Drug Discov 4 673 684
5. KJ Tracey A Cerami 1993 Tumor necrosis factor, other cytokines and disease Annu Rev Cell Biol 9 317 343
6. KJ Tracey A Cerami 1994 Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annu Rev Med 45 491 503
7. TJ Gan E Bennett-Guerrero B Phillips-Bute H Wakeling DM Moskowitz Y Olufolabi SN Konstadt C Bradford PS Glass SJ Machin MG Mythen 1999 Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group Anesth Analg 88 992 998
8. VG Nielsen S Tan AE Brix MS Baird DA Parks 1997 Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits Crit Care Med 25 1565 1574
9. JA Kellum 2002 Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline Crit Care Med 30 300 305
10. MT Handrigan TB Bentley JD Oliver LS Tabaku JR Burge JL Atkins 2005 Choice of fluid influences outcome in prolonged hypotensive resuscitation after hemorrhage in awake rats Shock 23 337 343
11. J Mapstone I Roberts P Evans 2003 Fluid resuscitation strategies: a systematic review of animal trials J Trauma 55 571 589
12. AR Cordell 1995 Milestones in the development of cardioplegia Ann Thorac Surg 60 793 796
13. TF Baskett 2003 The resuscitation greats: Sydney Ringer and lactated Ringer's solution Resuscitation 58 5 7
14. CM Montgomery AS Fairhurst JL Webb 1956 Metabolic studies on heart mitochondria. III. The action of parapyruvate on -α-ketoglutaric oxidase J Biol Chem 221 369 376
15. PN Slovin CJ Huang JR Cade CE Wood O Nasiroglu M Privette P Orbach JW Skimming 2001 Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock Resuscitation 50 109 115
16. RW Vonkorff 1964 Pyruvate-C14, purity and stability Anal Biochem 8 171 178
17. MP Fink 2008 Ethyl pyruvate Curr Opin Anaesthesiol 21 160 167
18. L Ulloa M Ochani H Yang M Tanovic D Halperin R Yang CJ Czura MP Fink KJ Tracey 2002 Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc Natl Acad Sci U S A 99 12351 12356
19. L Ulloa MP Fink KJ Tracey 2003 Ethyl pyruvate protects against lethal systemic inflammation by preventing HMGB1 release Ann NY Acad Sci 987 319 321
20. ZS Tawadrous RL Delude MP Fink 2002 Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats Shock 17 473 477
21. R Yang DJ Gallo JJ Baust T Uchiyama SK Watkins RL Delude MP Fink 2002 Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock Am J Physiol Gastrointest Liver Physiol 283 G212 G221
22. KE Mulier GJ Beilman MJ Conroy JH Taylor DE Skarda BE Hammer 2005 Ringer's ethyl pyruvate in hemorrhagic shock and resuscitation does not improve early hemodynamics or tissue energetics Shock 23 248 252
23. PL Sappington RJ Cruz Jr. T Harada R Yang Y Han JA Englert AA Ajami ME Killeen RL Delude MP Fink 2005 The ethyl pyruvate analogues, diethyl oxaloproprionate, 2-acetamidoacrylate, and methyl-2-acetamidoacrylate, exhibit anti-inflammatory properties in vivo and/or in vitro Biochem Pharmacol 70 1579 1592
24. F Su Z Wang Y Cai M Remmelink JL Vincent 2007 Beneficial effects of ethyl pyruvate in septic shock from peritonitis Arch Surg 142 166 171
25. NC Riedemann RF Guo PA Ward 2003 Novel strategies for the treatment of sepsis Nat Med 9 517 524
26. J Su X Li X Cui Y Li Y Fitz L Hsu H Mani M Quezado PQ Eichacker 2008 Ethyl pyruvate decreased early nuclear factor-kappaB levels but worsened survival in lipopolysaccharide-challenged mice Crit Care Med 36 1059 1067
27. JJ Tenhunen 2008 Bull's eye missed by the magic bullet: preclinical investigations, publication bias, and promising new interventions Crit Care Med 36 1361 1363
28. BT Peterson EJ Miller DE Griffith R Rowjee P McWaters 2000 Modulation by pentobarbital of neutrophil responses to inhaled E. coli endotoxin in sheep: role of lung epithelium Eur Respir J 16 697 703
29. J Wang R Charboneau S Balasubramanian RA Barke HH Loh S Roy 2002 The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor J Leukoc Biol 71 782 790
30. LJ Giassi AK Poynter JL Gainer 2002 Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapy Shock 18 585 588
31. CH Wu RT Bogusky JW Holcroft GC Kramer 1988 NMR monitoring of phosphate metabolism of rat skeletal muscle during hemorrhage and resuscitation J Trauma 28 757 764
32. Cai B, Chen F, Lin X, Levente K, Miller EJ, Szabo C, Deitch E, Ulloa L (2009) Anti-inflammatory adjuvant in resuscitation fluids improves survival in hemorrhage. Crit Care Med (in press)
33. D Ditsworth WX Zong CB Thompson 2007 Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus J Biol Chem 282 17845 17854
34. C Szabo 1998 Potential role of the peroxynitrate-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock Shock 9 341 344
35. L Virag C Szabo 2002 The therapeutic potential of poly(ADP-ribose) polymerase inhibitors Pharmacol Rev 54 375 429
36. P Jagtap C Szabo 2005 Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors Nat Rev Drug Discov 4 421 440
37. SA Stern SC Dronen P Birrer X Wang 1993 Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury Ann Emerg Med 22 155 163
38. Institute of Medicine Committee on Fluid Resuscitation for Combat Casualties (1999) Protocols of care at the cite of injury. D. N. A. P., Washington, pp 97-108
39. SD House X Mao G Wu D Espinelli WX Li SL Chang 2001 Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic-pituitary-adrenal axis J Neuroimmunol 118 277 285
40. PC Singhal M Bhaskaran J Patel K Patel BS Kasinath S Duraisamy N Franki K Reddy AA Kapasi 2002 Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis J Immunol 168 4025 4033
41. AA Malik N Radhakrishnan K Reddy AD Smith PC Singhal 2002 Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection J Endourol 16 605 610
42. JM Huston M Ochani M Rosas-Ballina H Liao K Ochani VA Pavlov M Gallowitsch-Puerta M Ashok CJ Czura B Foxwell KJ Tracey L Ulloa 2006 Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis J Exp Med 203 1623 1628
43. Y Han JA Englert R Yang RL Delude MP Fink 2005 Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65 J Pharmacol Exp Ther 312 1097 1105
44. L Liaudet FG Soriano E Szabo L Virag JG Mabley AL Salzman C Szabo 2000 Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase Proc Natl Acad Sci U S A 97 10203 10208
45. YJ Woo MD Taylor JE Cohen V Jayasankar LT Bish J Burdick TJ Pirolli MF Berry V Hsu T Grand 2004 Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia J Thorac Cardiovasc Surg 127 1262 1269
46. PA Baeuerle T Henkel 1994 Function and activation of NF-kappa B in the immune system Annu Rev Immunol 12 141 179
47. Q Li IM Verma 2002 NF-kappaB regulation in the immune system Nat Rev Immunol 2 725 734
48. MS Hayden AP West S Ghosh 2006 NF-kappaB and the immune response Oncogene 25 6758 6780
49. ZW Li W Chu Y Hu M Delhase T Deerinck M Ellisman R Johnson M Karin 1999 The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis J Exp Med 189 1839 1845
50. Q Li D Van Antwerp F Mercurio KF Lee IM Verma 1999 Severe liver degeneration in mice lacking the IkappaB kinase 2 gene Science 284 321 325
51. M Tanaka ME Fuentes K Yamaguchi MH Durnin SA Dalrymple KL Hardy DV Goeddel 1999 Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice Immunity 10 421 429
52. AA Beg WC Sha RT Bronson S Ghosh D Baltimore 1995 Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B Nature 376 167 170
53. E Alcamo N Hacohen LC Schulte PD Rennert RO Hynes D Baltimore 2002 Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs J Exp Med 195 233 244
54. TS Doi MW Marino T Takahashi T Yoshida T Sakakura LJ Old Y Obata 1999 Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality Proc Natl Acad Sci U S A 96 2994 2999
55. LL Mantell WR Parrish L Ulloa 2006 HMGB1 as a therapeutic target for infectious and inflammatory disorders Shock 25 4 11